Global DPT Series Vaccine Market Growth 2026-2032
The global DPT Series Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for DPT Series Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for DPT Series Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for DPT Series Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key DPT Series Vaccine players cover Sanofi, GSK, AJ Vaccines, Panacea Biotec, CNBG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?DPT Series Vaccine Industry Forecast? looks at past sales and reviews total world DPT Series Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected DPT Series Vaccine sales for 2026 through 2032. With DPT Series Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world DPT Series Vaccine industry.
This Insight Report provides a comprehensive analysis of the global DPT Series Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on DPT Series Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global DPT Series Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for DPT Series Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global DPT Series Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of DPT Series Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
United States market for DPT Series Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for DPT Series Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for DPT Series Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key DPT Series Vaccine players cover Sanofi, GSK, AJ Vaccines, Panacea Biotec, CNBG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?DPT Series Vaccine Industry Forecast? looks at past sales and reviews total world DPT Series Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected DPT Series Vaccine sales for 2026 through 2032. With DPT Series Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world DPT Series Vaccine industry.
This Insight Report provides a comprehensive analysis of the global DPT Series Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on DPT Series Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global DPT Series Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for DPT Series Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global DPT Series Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of DPT Series Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Absorbed Diphtheria-Tetanus Combined Vaccine
- Absorbed Tetanus Vaccine
- Absorbed Acellular Diphtheria-Tetanus-Pertussis Combined Vaccine
- DTP-Hib Quadruple Vaccine
- DTP-IPV-Hib Pentavalent Vaccine
- Adults
- Children
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- GSK
- AJ Vaccines
- Panacea Biotec
- CNBG
- Hualan Biological Vaccine
- BioKangtai
- Walvax Biotechnology
- CanSino Biologics
- Chongqing Zhifei Biological Products
- What is the 10-year outlook for the global DPT Series Vaccine market?
- What factors are driving DPT Series Vaccine market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do DPT Series Vaccine market opportunities vary by end market size?
- How does DPT Series Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global DPT Series Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for DPT Series Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for DPT Series Vaccine by Country/Region, 2021, 2025 & 2032
2.2 DPT Series Vaccine Segment by Type
2.2.1 Absorbed Diphtheria-Tetanus Combined Vaccine
2.2.2 Absorbed Tetanus Vaccine
2.2.3 Absorbed Acellular Diphtheria-Tetanus-Pertussis Combined Vaccine
2.2.4 DTP-Hib Quadruple Vaccine
2.2.5 DTP-IPV-Hib Pentavalent Vaccine
2.2.6 DPT Series Vaccine Sales by Type
2.2.6.1 Global DPT Series Vaccine Sales Market Share by Type (2021-2026)
2.2.6.2 Global DPT Series Vaccine Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global DPT Series Vaccine Sale Price by Type (2021-2026)
2.3 DPT Series Vaccine Segment by Application
2.3.1 Adults
2.3.2 Children
2.3.3 DPT Series Vaccine Sales by Application
2.3.3.1 Global DPT Series Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global DPT Series Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global DPT Series Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global DPT Series Vaccine Breakdown Data by Company
3.1.1 Global DPT Series Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global DPT Series Vaccine Sales Market Share by Company (2021-2026)
3.2 Global DPT Series Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global DPT Series Vaccine Revenue by Company (2021-2026)
3.2.2 Global DPT Series Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global DPT Series Vaccine Sale Price by Company
3.4 Key Manufacturers DPT Series Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers DPT Series Vaccine Product Location Distribution
3.4.2 Players DPT Series Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DPT SERIES VACCINE BY GEOGRAPHIC REGION
4.1 World Historic DPT Series Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global DPT Series Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global DPT Series Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic DPT Series Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global DPT Series Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global DPT Series Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas DPT Series Vaccine Sales Growth
4.4 APAC DPT Series Vaccine Sales Growth
4.5 Europe DPT Series Vaccine Sales Growth
4.6 Middle East & Africa DPT Series Vaccine Sales Growth
5 AMERICAS
5.1 Americas DPT Series Vaccine Sales by Country
5.1.1 Americas DPT Series Vaccine Sales by Country (2021-2026)
5.1.2 Americas DPT Series Vaccine Revenue by Country (2021-2026)
5.2 Americas DPT Series Vaccine Sales by Type (2021-2026)
5.3 Americas DPT Series Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC DPT Series Vaccine Sales by Region
6.1.1 APAC DPT Series Vaccine Sales by Region (2021-2026)
6.1.2 APAC DPT Series Vaccine Revenue by Region (2021-2026)
6.2 APAC DPT Series Vaccine Sales by Type (2021-2026)
6.3 APAC DPT Series Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe DPT Series Vaccine by Country
7.1.1 Europe DPT Series Vaccine Sales by Country (2021-2026)
7.1.2 Europe DPT Series Vaccine Revenue by Country (2021-2026)
7.2 Europe DPT Series Vaccine Sales by Type (2021-2026)
7.3 Europe DPT Series Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa DPT Series Vaccine by Country
8.1.1 Middle East & Africa DPT Series Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa DPT Series Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa DPT Series Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa DPT Series Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of DPT Series Vaccine
10.3 Manufacturing Process Analysis of DPT Series Vaccine
10.4 Industry Chain Structure of DPT Series Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 DPT Series Vaccine Distributors
11.3 DPT Series Vaccine Customer
12 WORLD FORECAST REVIEW FOR DPT SERIES VACCINE BY GEOGRAPHIC REGION
12.1 Global DPT Series Vaccine Market Size Forecast by Region
12.1.1 Global DPT Series Vaccine Forecast by Region (2027-2032)
12.1.2 Global DPT Series Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global DPT Series Vaccine Forecast by Type (2027-2032)
12.7 Global DPT Series Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi DPT Series Vaccine Product Portfolios and Specifications
13.1.3 Sanofi DPT Series Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK DPT Series Vaccine Product Portfolios and Specifications
13.2.3 GSK DPT Series Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 AJ Vaccines
13.3.1 AJ Vaccines Company Information
13.3.2 AJ Vaccines DPT Series Vaccine Product Portfolios and Specifications
13.3.3 AJ Vaccines DPT Series Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 AJ Vaccines Main Business Overview
13.3.5 AJ Vaccines Latest Developments
13.4 Panacea Biotec
13.4.1 Panacea Biotec Company Information
13.4.2 Panacea Biotec DPT Series Vaccine Product Portfolios and Specifications
13.4.3 Panacea Biotec DPT Series Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Panacea Biotec Main Business Overview
13.4.5 Panacea Biotec Latest Developments
13.5 CNBG
13.5.1 CNBG Company Information
13.5.2 CNBG DPT Series Vaccine Product Portfolios and Specifications
13.5.3 CNBG DPT Series Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 CNBG Main Business Overview
13.5.5 CNBG Latest Developments
13.6 Hualan Biological Vaccine
13.6.1 Hualan Biological Vaccine Company Information
13.6.2 Hualan Biological Vaccine DPT Series Vaccine Product Portfolios and Specifications
13.6.3 Hualan Biological Vaccine DPT Series Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Hualan Biological Vaccine Main Business Overview
13.6.5 Hualan Biological Vaccine Latest Developments
13.7 BioKangtai
13.7.1 BioKangtai Company Information
13.7.2 BioKangtai DPT Series Vaccine Product Portfolios and Specifications
13.7.3 BioKangtai DPT Series Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 BioKangtai Main Business Overview
13.7.5 BioKangtai Latest Developments
13.8 Walvax Biotechnology
13.8.1 Walvax Biotechnology Company Information
13.8.2 Walvax Biotechnology DPT Series Vaccine Product Portfolios and Specifications
13.8.3 Walvax Biotechnology DPT Series Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Walvax Biotechnology Main Business Overview
13.8.5 Walvax Biotechnology Latest Developments
13.9 CanSino Biologics
13.9.1 CanSino Biologics Company Information
13.9.2 CanSino Biologics DPT Series Vaccine Product Portfolios and Specifications
13.9.3 CanSino Biologics DPT Series Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 CanSino Biologics Main Business Overview
13.9.5 CanSino Biologics Latest Developments
13.10 Chongqing Zhifei Biological Products
13.10.1 Chongqing Zhifei Biological Products Company Information
13.10.2 Chongqing Zhifei Biological Products DPT Series Vaccine Product Portfolios and Specifications
13.10.3 Chongqing Zhifei Biological Products DPT Series Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Chongqing Zhifei Biological Products Main Business Overview
13.10.5 Chongqing Zhifei Biological Products Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global DPT Series Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for DPT Series Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for DPT Series Vaccine by Country/Region, 2021, 2025 & 2032
2.2 DPT Series Vaccine Segment by Type
2.2.1 Absorbed Diphtheria-Tetanus Combined Vaccine
2.2.2 Absorbed Tetanus Vaccine
2.2.3 Absorbed Acellular Diphtheria-Tetanus-Pertussis Combined Vaccine
2.2.4 DTP-Hib Quadruple Vaccine
2.2.5 DTP-IPV-Hib Pentavalent Vaccine
2.2.6 DPT Series Vaccine Sales by Type
2.2.6.1 Global DPT Series Vaccine Sales Market Share by Type (2021-2026)
2.2.6.2 Global DPT Series Vaccine Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global DPT Series Vaccine Sale Price by Type (2021-2026)
2.3 DPT Series Vaccine Segment by Application
2.3.1 Adults
2.3.2 Children
2.3.3 DPT Series Vaccine Sales by Application
2.3.3.1 Global DPT Series Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global DPT Series Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global DPT Series Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global DPT Series Vaccine Breakdown Data by Company
3.1.1 Global DPT Series Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global DPT Series Vaccine Sales Market Share by Company (2021-2026)
3.2 Global DPT Series Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global DPT Series Vaccine Revenue by Company (2021-2026)
3.2.2 Global DPT Series Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global DPT Series Vaccine Sale Price by Company
3.4 Key Manufacturers DPT Series Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers DPT Series Vaccine Product Location Distribution
3.4.2 Players DPT Series Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DPT SERIES VACCINE BY GEOGRAPHIC REGION
4.1 World Historic DPT Series Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global DPT Series Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global DPT Series Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic DPT Series Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global DPT Series Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global DPT Series Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas DPT Series Vaccine Sales Growth
4.4 APAC DPT Series Vaccine Sales Growth
4.5 Europe DPT Series Vaccine Sales Growth
4.6 Middle East & Africa DPT Series Vaccine Sales Growth
5 AMERICAS
5.1 Americas DPT Series Vaccine Sales by Country
5.1.1 Americas DPT Series Vaccine Sales by Country (2021-2026)
5.1.2 Americas DPT Series Vaccine Revenue by Country (2021-2026)
5.2 Americas DPT Series Vaccine Sales by Type (2021-2026)
5.3 Americas DPT Series Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC DPT Series Vaccine Sales by Region
6.1.1 APAC DPT Series Vaccine Sales by Region (2021-2026)
6.1.2 APAC DPT Series Vaccine Revenue by Region (2021-2026)
6.2 APAC DPT Series Vaccine Sales by Type (2021-2026)
6.3 APAC DPT Series Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe DPT Series Vaccine by Country
7.1.1 Europe DPT Series Vaccine Sales by Country (2021-2026)
7.1.2 Europe DPT Series Vaccine Revenue by Country (2021-2026)
7.2 Europe DPT Series Vaccine Sales by Type (2021-2026)
7.3 Europe DPT Series Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa DPT Series Vaccine by Country
8.1.1 Middle East & Africa DPT Series Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa DPT Series Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa DPT Series Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa DPT Series Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of DPT Series Vaccine
10.3 Manufacturing Process Analysis of DPT Series Vaccine
10.4 Industry Chain Structure of DPT Series Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 DPT Series Vaccine Distributors
11.3 DPT Series Vaccine Customer
12 WORLD FORECAST REVIEW FOR DPT SERIES VACCINE BY GEOGRAPHIC REGION
12.1 Global DPT Series Vaccine Market Size Forecast by Region
12.1.1 Global DPT Series Vaccine Forecast by Region (2027-2032)
12.1.2 Global DPT Series Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global DPT Series Vaccine Forecast by Type (2027-2032)
12.7 Global DPT Series Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi DPT Series Vaccine Product Portfolios and Specifications
13.1.3 Sanofi DPT Series Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK DPT Series Vaccine Product Portfolios and Specifications
13.2.3 GSK DPT Series Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 AJ Vaccines
13.3.1 AJ Vaccines Company Information
13.3.2 AJ Vaccines DPT Series Vaccine Product Portfolios and Specifications
13.3.3 AJ Vaccines DPT Series Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 AJ Vaccines Main Business Overview
13.3.5 AJ Vaccines Latest Developments
13.4 Panacea Biotec
13.4.1 Panacea Biotec Company Information
13.4.2 Panacea Biotec DPT Series Vaccine Product Portfolios and Specifications
13.4.3 Panacea Biotec DPT Series Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Panacea Biotec Main Business Overview
13.4.5 Panacea Biotec Latest Developments
13.5 CNBG
13.5.1 CNBG Company Information
13.5.2 CNBG DPT Series Vaccine Product Portfolios and Specifications
13.5.3 CNBG DPT Series Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 CNBG Main Business Overview
13.5.5 CNBG Latest Developments
13.6 Hualan Biological Vaccine
13.6.1 Hualan Biological Vaccine Company Information
13.6.2 Hualan Biological Vaccine DPT Series Vaccine Product Portfolios and Specifications
13.6.3 Hualan Biological Vaccine DPT Series Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Hualan Biological Vaccine Main Business Overview
13.6.5 Hualan Biological Vaccine Latest Developments
13.7 BioKangtai
13.7.1 BioKangtai Company Information
13.7.2 BioKangtai DPT Series Vaccine Product Portfolios and Specifications
13.7.3 BioKangtai DPT Series Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 BioKangtai Main Business Overview
13.7.5 BioKangtai Latest Developments
13.8 Walvax Biotechnology
13.8.1 Walvax Biotechnology Company Information
13.8.2 Walvax Biotechnology DPT Series Vaccine Product Portfolios and Specifications
13.8.3 Walvax Biotechnology DPT Series Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Walvax Biotechnology Main Business Overview
13.8.5 Walvax Biotechnology Latest Developments
13.9 CanSino Biologics
13.9.1 CanSino Biologics Company Information
13.9.2 CanSino Biologics DPT Series Vaccine Product Portfolios and Specifications
13.9.3 CanSino Biologics DPT Series Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 CanSino Biologics Main Business Overview
13.9.5 CanSino Biologics Latest Developments
13.10 Chongqing Zhifei Biological Products
13.10.1 Chongqing Zhifei Biological Products Company Information
13.10.2 Chongqing Zhifei Biological Products DPT Series Vaccine Product Portfolios and Specifications
13.10.3 Chongqing Zhifei Biological Products DPT Series Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Chongqing Zhifei Biological Products Main Business Overview
13.10.5 Chongqing Zhifei Biological Products Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. DPT Series Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. DPT Series Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Absorbed Diphtheria-Tetanus Combined Vaccine
Table 4. Major Players of Absorbed Tetanus Vaccine
Table 5. Major Players of Absorbed Acellular Diphtheria-Tetanus-Pertussis Combined Vaccine
Table 6. Major Players of DTP-Hib Quadruple Vaccine
Table 7. Major Players of DTP-IPV-Hib Pentavalent Vaccine
Table 8. Global DPT Series Vaccine Sales by Type (2021-2026) & (K Units)
Table 9. Global DPT Series Vaccine Sales Market Share by Type (2021-2026)
Table 10. Global DPT Series Vaccine Revenue by Type (2021-2026) & ($ million)
Table 11. Global DPT Series Vaccine Revenue Market Share by Type (2021-2026)
Table 12. Global DPT Series Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Global DPT Series Vaccine Sale by Application (2021-2026) & (K Units)
Table 14. Global DPT Series Vaccine Sale Market Share by Application (2021-2026)
Table 15. Global DPT Series Vaccine Revenue by Application (2021-2026) & ($ million)
Table 16. Global DPT Series Vaccine Revenue Market Share by Application (2021-2026)
Table 17. Global DPT Series Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 18. Global DPT Series Vaccine Sales by Company (2021-2026) & (K Units)
Table 19. Global DPT Series Vaccine Sales Market Share by Company (2021-2026)
Table 20. Global DPT Series Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 21. Global DPT Series Vaccine Revenue Market Share by Company (2021-2026)
Table 22. Global DPT Series Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 23. Key Manufacturers DPT Series Vaccine Producing Area Distribution and Sales Area
Table 24. Players DPT Series Vaccine Products Offered
Table 25. DPT Series Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global DPT Series Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 29. Global DPT Series Vaccine Sales Market Share Geographic Region (2021-2026)
Table 30. Global DPT Series Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global DPT Series Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global DPT Series Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 33. Global DPT Series Vaccine Sales Market Share by Country/Region (2021-2026)
Table 34. Global DPT Series Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global DPT Series Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas DPT Series Vaccine Sales by Country (2021-2026) & (K Units)
Table 37. Americas DPT Series Vaccine Sales Market Share by Country (2021-2026)
Table 38. Americas DPT Series Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas DPT Series Vaccine Sales by Type (2021-2026) & (K Units)
Table 40. Americas DPT Series Vaccine Sales by Application (2021-2026) & (K Units)
Table 41. APAC DPT Series Vaccine Sales by Region (2021-2026) & (K Units)
Table 42. APAC DPT Series Vaccine Sales Market Share by Region (2021-2026)
Table 43. APAC DPT Series Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC DPT Series Vaccine Sales by Type (2021-2026) & (K Units)
Table 45. APAC DPT Series Vaccine Sales by Application (2021-2026) & (K Units)
Table 46. Europe DPT Series Vaccine Sales by Country (2021-2026) & (K Units)
Table 47. Europe DPT Series Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe DPT Series Vaccine Sales by Type (2021-2026) & (K Units)
Table 49. Europe DPT Series Vaccine Sales by Application (2021-2026) & (K Units)
Table 50. Middle East & Africa DPT Series Vaccine Sales by Country (2021-2026) & (K Units)
Table 51. Middle East & Africa DPT Series Vaccine Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa DPT Series Vaccine Sales by Type (2021-2026) & (K Units)
Table 53. Middle East & Africa DPT Series Vaccine Sales by Application (2021-2026) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of DPT Series Vaccine
Table 55. Key Market Challenges & Risks of DPT Series Vaccine
Table 56. Key Industry Trends of DPT Series Vaccine
Table 57. DPT Series Vaccine Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. DPT Series Vaccine Distributors List
Table 60. DPT Series Vaccine Customer List
Table 61. Global DPT Series Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 62. Global DPT Series Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas DPT Series Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 64. Americas DPT Series Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC DPT Series Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 66. APAC DPT Series Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe DPT Series Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Europe DPT Series Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa DPT Series Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Middle East & Africa DPT Series Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global DPT Series Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 72. Global DPT Series Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global DPT Series Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 74. Global DPT Series Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. Sanofi Basic Information, DPT Series Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 76. Sanofi DPT Series Vaccine Product Portfolios and Specifications
Table 77. Sanofi DPT Series Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. Sanofi Main Business
Table 79. Sanofi Latest Developments
Table 80. GSK Basic Information, DPT Series Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 81. GSK DPT Series Vaccine Product Portfolios and Specifications
Table 82. GSK DPT Series Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. GSK Main Business
Table 84. GSK Latest Developments
Table 85. AJ Vaccines Basic Information, DPT Series Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 86. AJ Vaccines DPT Series Vaccine Product Portfolios and Specifications
Table 87. AJ Vaccines DPT Series Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. AJ Vaccines Main Business
Table 89. AJ Vaccines Latest Developments
Table 90. Panacea Biotec Basic Information, DPT Series Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 91. Panacea Biotec DPT Series Vaccine Product Portfolios and Specifications
Table 92. Panacea Biotec DPT Series Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Panacea Biotec Main Business
Table 94. Panacea Biotec Latest Developments
Table 95. CNBG Basic Information, DPT Series Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 96. CNBG DPT Series Vaccine Product Portfolios and Specifications
Table 97. CNBG DPT Series Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. CNBG Main Business
Table 99. CNBG Latest Developments
Table 100. Hualan Biological Vaccine Basic Information, DPT Series Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 101. Hualan Biological Vaccine DPT Series Vaccine Product Portfolios and Specifications
Table 102. Hualan Biological Vaccine DPT Series Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Hualan Biological Vaccine Main Business
Table 104. Hualan Biological Vaccine Latest Developments
Table 105. BioKangtai Basic Information, DPT Series Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 106. BioKangtai DPT Series Vaccine Product Portfolios and Specifications
Table 107. BioKangtai DPT Series Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. BioKangtai Main Business
Table 109. BioKangtai Latest Developments
Table 110. Walvax Biotechnology Basic Information, DPT Series Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 111. Walvax Biotechnology DPT Series Vaccine Product Portfolios and Specifications
Table 112. Walvax Biotechnology DPT Series Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Walvax Biotechnology Main Business
Table 114. Walvax Biotechnology Latest Developments
Table 115. CanSino Biologics Basic Information, DPT Series Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 116. CanSino Biologics DPT Series Vaccine Product Portfolios and Specifications
Table 117. CanSino Biologics DPT Series Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. CanSino Biologics Main Business
Table 119. CanSino Biologics Latest Developments
Table 120. Chongqing Zhifei Biological Products Basic Information, DPT Series Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 121. Chongqing Zhifei Biological Products DPT Series Vaccine Product Portfolios and Specifications
Table 122. Chongqing Zhifei Biological Products DPT Series Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Chongqing Zhifei Biological Products Main Business
Table 124. Chongqing Zhifei Biological Products Latest Developments
Table 1. DPT Series Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. DPT Series Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Absorbed Diphtheria-Tetanus Combined Vaccine
Table 4. Major Players of Absorbed Tetanus Vaccine
Table 5. Major Players of Absorbed Acellular Diphtheria-Tetanus-Pertussis Combined Vaccine
Table 6. Major Players of DTP-Hib Quadruple Vaccine
Table 7. Major Players of DTP-IPV-Hib Pentavalent Vaccine
Table 8. Global DPT Series Vaccine Sales by Type (2021-2026) & (K Units)
Table 9. Global DPT Series Vaccine Sales Market Share by Type (2021-2026)
Table 10. Global DPT Series Vaccine Revenue by Type (2021-2026) & ($ million)
Table 11. Global DPT Series Vaccine Revenue Market Share by Type (2021-2026)
Table 12. Global DPT Series Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Global DPT Series Vaccine Sale by Application (2021-2026) & (K Units)
Table 14. Global DPT Series Vaccine Sale Market Share by Application (2021-2026)
Table 15. Global DPT Series Vaccine Revenue by Application (2021-2026) & ($ million)
Table 16. Global DPT Series Vaccine Revenue Market Share by Application (2021-2026)
Table 17. Global DPT Series Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 18. Global DPT Series Vaccine Sales by Company (2021-2026) & (K Units)
Table 19. Global DPT Series Vaccine Sales Market Share by Company (2021-2026)
Table 20. Global DPT Series Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 21. Global DPT Series Vaccine Revenue Market Share by Company (2021-2026)
Table 22. Global DPT Series Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 23. Key Manufacturers DPT Series Vaccine Producing Area Distribution and Sales Area
Table 24. Players DPT Series Vaccine Products Offered
Table 25. DPT Series Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global DPT Series Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 29. Global DPT Series Vaccine Sales Market Share Geographic Region (2021-2026)
Table 30. Global DPT Series Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global DPT Series Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global DPT Series Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 33. Global DPT Series Vaccine Sales Market Share by Country/Region (2021-2026)
Table 34. Global DPT Series Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global DPT Series Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas DPT Series Vaccine Sales by Country (2021-2026) & (K Units)
Table 37. Americas DPT Series Vaccine Sales Market Share by Country (2021-2026)
Table 38. Americas DPT Series Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas DPT Series Vaccine Sales by Type (2021-2026) & (K Units)
Table 40. Americas DPT Series Vaccine Sales by Application (2021-2026) & (K Units)
Table 41. APAC DPT Series Vaccine Sales by Region (2021-2026) & (K Units)
Table 42. APAC DPT Series Vaccine Sales Market Share by Region (2021-2026)
Table 43. APAC DPT Series Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC DPT Series Vaccine Sales by Type (2021-2026) & (K Units)
Table 45. APAC DPT Series Vaccine Sales by Application (2021-2026) & (K Units)
Table 46. Europe DPT Series Vaccine Sales by Country (2021-2026) & (K Units)
Table 47. Europe DPT Series Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe DPT Series Vaccine Sales by Type (2021-2026) & (K Units)
Table 49. Europe DPT Series Vaccine Sales by Application (2021-2026) & (K Units)
Table 50. Middle East & Africa DPT Series Vaccine Sales by Country (2021-2026) & (K Units)
Table 51. Middle East & Africa DPT Series Vaccine Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa DPT Series Vaccine Sales by Type (2021-2026) & (K Units)
Table 53. Middle East & Africa DPT Series Vaccine Sales by Application (2021-2026) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of DPT Series Vaccine
Table 55. Key Market Challenges & Risks of DPT Series Vaccine
Table 56. Key Industry Trends of DPT Series Vaccine
Table 57. DPT Series Vaccine Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. DPT Series Vaccine Distributors List
Table 60. DPT Series Vaccine Customer List
Table 61. Global DPT Series Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 62. Global DPT Series Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas DPT Series Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 64. Americas DPT Series Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC DPT Series Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 66. APAC DPT Series Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe DPT Series Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Europe DPT Series Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa DPT Series Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Middle East & Africa DPT Series Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global DPT Series Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 72. Global DPT Series Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global DPT Series Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 74. Global DPT Series Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. Sanofi Basic Information, DPT Series Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 76. Sanofi DPT Series Vaccine Product Portfolios and Specifications
Table 77. Sanofi DPT Series Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. Sanofi Main Business
Table 79. Sanofi Latest Developments
Table 80. GSK Basic Information, DPT Series Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 81. GSK DPT Series Vaccine Product Portfolios and Specifications
Table 82. GSK DPT Series Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. GSK Main Business
Table 84. GSK Latest Developments
Table 85. AJ Vaccines Basic Information, DPT Series Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 86. AJ Vaccines DPT Series Vaccine Product Portfolios and Specifications
Table 87. AJ Vaccines DPT Series Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. AJ Vaccines Main Business
Table 89. AJ Vaccines Latest Developments
Table 90. Panacea Biotec Basic Information, DPT Series Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 91. Panacea Biotec DPT Series Vaccine Product Portfolios and Specifications
Table 92. Panacea Biotec DPT Series Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Panacea Biotec Main Business
Table 94. Panacea Biotec Latest Developments
Table 95. CNBG Basic Information, DPT Series Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 96. CNBG DPT Series Vaccine Product Portfolios and Specifications
Table 97. CNBG DPT Series Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. CNBG Main Business
Table 99. CNBG Latest Developments
Table 100. Hualan Biological Vaccine Basic Information, DPT Series Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 101. Hualan Biological Vaccine DPT Series Vaccine Product Portfolios and Specifications
Table 102. Hualan Biological Vaccine DPT Series Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Hualan Biological Vaccine Main Business
Table 104. Hualan Biological Vaccine Latest Developments
Table 105. BioKangtai Basic Information, DPT Series Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 106. BioKangtai DPT Series Vaccine Product Portfolios and Specifications
Table 107. BioKangtai DPT Series Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. BioKangtai Main Business
Table 109. BioKangtai Latest Developments
Table 110. Walvax Biotechnology Basic Information, DPT Series Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 111. Walvax Biotechnology DPT Series Vaccine Product Portfolios and Specifications
Table 112. Walvax Biotechnology DPT Series Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Walvax Biotechnology Main Business
Table 114. Walvax Biotechnology Latest Developments
Table 115. CanSino Biologics Basic Information, DPT Series Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 116. CanSino Biologics DPT Series Vaccine Product Portfolios and Specifications
Table 117. CanSino Biologics DPT Series Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. CanSino Biologics Main Business
Table 119. CanSino Biologics Latest Developments
Table 120. Chongqing Zhifei Biological Products Basic Information, DPT Series Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 121. Chongqing Zhifei Biological Products DPT Series Vaccine Product Portfolios and Specifications
Table 122. Chongqing Zhifei Biological Products DPT Series Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Chongqing Zhifei Biological Products Main Business
Table 124. Chongqing Zhifei Biological Products Latest Developments
LIST OF FIGURES
Figure 1. Picture of DPT Series Vaccine
Figure 2. DPT Series Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global DPT Series Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global DPT Series Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. DPT Series Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. DPT Series Vaccine Sales Market Share by Country/Region (2025)
Figure 10. DPT Series Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Absorbed Diphtheria-Tetanus Combined Vaccine
Figure 12. Product Picture of Absorbed Tetanus Vaccine
Figure 13. Product Picture of Absorbed Acellular Diphtheria-Tetanus-Pertussis Combined Vaccine
Figure 14. Product Picture of DTP-Hib Quadruple Vaccine
Figure 15. Product Picture of DTP-IPV-Hib Pentavalent Vaccine
Figure 16. Global DPT Series Vaccine Sales Market Share by Type in 2026
Figure 17. Global DPT Series Vaccine Revenue Market Share by Type (2021-2026)
Figure 18. DPT Series Vaccine Consumed in Adults
Figure 19. Global DPT Series Vaccine Market: Adults (2021-2026) & (K Units)
Figure 20. DPT Series Vaccine Consumed in Children
Figure 21. Global DPT Series Vaccine Market: Children (2021-2026) & (K Units)
Figure 22. Global DPT Series Vaccine Sale Market Share by Application (2025)
Figure 23. Global DPT Series Vaccine Revenue Market Share by Application in 2026
Figure 24. DPT Series Vaccine Sales by Company in 2026 (K Units)
Figure 25. Global DPT Series Vaccine Sales Market Share by Company in 2026
Figure 26. DPT Series Vaccine Revenue by Company in 2026 ($ millions)
Figure 27. Global DPT Series Vaccine Revenue Market Share by Company in 2026
Figure 28. Global DPT Series Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global DPT Series Vaccine Revenue Market Share by Geographic Region in 2026
Figure 30. Americas DPT Series Vaccine Sales 2021-2026 (K Units)
Figure 31. Americas DPT Series Vaccine Revenue 2021-2026 ($ millions)
Figure 32. APAC DPT Series Vaccine Sales 2021-2026 (K Units)
Figure 33. APAC DPT Series Vaccine Revenue 2021-2026 ($ millions)
Figure 34. Europe DPT Series Vaccine Sales 2021-2026 (K Units)
Figure 35. Europe DPT Series Vaccine Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa DPT Series Vaccine Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa DPT Series Vaccine Revenue 2021-2026 ($ millions)
Figure 38. Americas DPT Series Vaccine Sales Market Share by Country in 2026
Figure 39. Americas DPT Series Vaccine Revenue Market Share by Country (2021-2026)
Figure 40. Americas DPT Series Vaccine Sales Market Share by Type (2021-2026)
Figure 41. Americas DPT Series Vaccine Sales Market Share by Application (2021-2026)
Figure 42. United States DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC DPT Series Vaccine Sales Market Share by Region in 2026
Figure 47. APAC DPT Series Vaccine Revenue Market Share by Region (2021-2026)
Figure 48. APAC DPT Series Vaccine Sales Market Share by Type (2021-2026)
Figure 49. APAC DPT Series Vaccine Sales Market Share by Application (2021-2026)
Figure 50. China DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. India DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe DPT Series Vaccine Sales Market Share by Country in 2026
Figure 58. Europe DPT Series Vaccine Revenue Market Share by Country (2021-2026)
Figure 59. Europe DPT Series Vaccine Sales Market Share by Type (2021-2026)
Figure 60. Europe DPT Series Vaccine Sales Market Share by Application (2021-2026)
Figure 61. Germany DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. France DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. UK DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa DPT Series Vaccine Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa DPT Series Vaccine Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa DPT Series Vaccine Sales Market Share by Application (2021-2026)
Figure 69. Egypt DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of DPT Series Vaccine in 2026
Figure 75. Manufacturing Process Analysis of DPT Series Vaccine
Figure 76. Industry Chain Structure of DPT Series Vaccine
Figure 77. Channels of Distribution
Figure 78. Global DPT Series Vaccine Sales Market Forecast by Region (2027-2032)
Figure 79. Global DPT Series Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global DPT Series Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global DPT Series Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global DPT Series Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global DPT Series Vaccine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of DPT Series Vaccine
Figure 2. DPT Series Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global DPT Series Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global DPT Series Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. DPT Series Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. DPT Series Vaccine Sales Market Share by Country/Region (2025)
Figure 10. DPT Series Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Absorbed Diphtheria-Tetanus Combined Vaccine
Figure 12. Product Picture of Absorbed Tetanus Vaccine
Figure 13. Product Picture of Absorbed Acellular Diphtheria-Tetanus-Pertussis Combined Vaccine
Figure 14. Product Picture of DTP-Hib Quadruple Vaccine
Figure 15. Product Picture of DTP-IPV-Hib Pentavalent Vaccine
Figure 16. Global DPT Series Vaccine Sales Market Share by Type in 2026
Figure 17. Global DPT Series Vaccine Revenue Market Share by Type (2021-2026)
Figure 18. DPT Series Vaccine Consumed in Adults
Figure 19. Global DPT Series Vaccine Market: Adults (2021-2026) & (K Units)
Figure 20. DPT Series Vaccine Consumed in Children
Figure 21. Global DPT Series Vaccine Market: Children (2021-2026) & (K Units)
Figure 22. Global DPT Series Vaccine Sale Market Share by Application (2025)
Figure 23. Global DPT Series Vaccine Revenue Market Share by Application in 2026
Figure 24. DPT Series Vaccine Sales by Company in 2026 (K Units)
Figure 25. Global DPT Series Vaccine Sales Market Share by Company in 2026
Figure 26. DPT Series Vaccine Revenue by Company in 2026 ($ millions)
Figure 27. Global DPT Series Vaccine Revenue Market Share by Company in 2026
Figure 28. Global DPT Series Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global DPT Series Vaccine Revenue Market Share by Geographic Region in 2026
Figure 30. Americas DPT Series Vaccine Sales 2021-2026 (K Units)
Figure 31. Americas DPT Series Vaccine Revenue 2021-2026 ($ millions)
Figure 32. APAC DPT Series Vaccine Sales 2021-2026 (K Units)
Figure 33. APAC DPT Series Vaccine Revenue 2021-2026 ($ millions)
Figure 34. Europe DPT Series Vaccine Sales 2021-2026 (K Units)
Figure 35. Europe DPT Series Vaccine Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa DPT Series Vaccine Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa DPT Series Vaccine Revenue 2021-2026 ($ millions)
Figure 38. Americas DPT Series Vaccine Sales Market Share by Country in 2026
Figure 39. Americas DPT Series Vaccine Revenue Market Share by Country (2021-2026)
Figure 40. Americas DPT Series Vaccine Sales Market Share by Type (2021-2026)
Figure 41. Americas DPT Series Vaccine Sales Market Share by Application (2021-2026)
Figure 42. United States DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC DPT Series Vaccine Sales Market Share by Region in 2026
Figure 47. APAC DPT Series Vaccine Revenue Market Share by Region (2021-2026)
Figure 48. APAC DPT Series Vaccine Sales Market Share by Type (2021-2026)
Figure 49. APAC DPT Series Vaccine Sales Market Share by Application (2021-2026)
Figure 50. China DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. India DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe DPT Series Vaccine Sales Market Share by Country in 2026
Figure 58. Europe DPT Series Vaccine Revenue Market Share by Country (2021-2026)
Figure 59. Europe DPT Series Vaccine Sales Market Share by Type (2021-2026)
Figure 60. Europe DPT Series Vaccine Sales Market Share by Application (2021-2026)
Figure 61. Germany DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. France DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. UK DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa DPT Series Vaccine Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa DPT Series Vaccine Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa DPT Series Vaccine Sales Market Share by Application (2021-2026)
Figure 69. Egypt DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries DPT Series Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of DPT Series Vaccine in 2026
Figure 75. Manufacturing Process Analysis of DPT Series Vaccine
Figure 76. Industry Chain Structure of DPT Series Vaccine
Figure 77. Channels of Distribution
Figure 78. Global DPT Series Vaccine Sales Market Forecast by Region (2027-2032)
Figure 79. Global DPT Series Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global DPT Series Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global DPT Series Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global DPT Series Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global DPT Series Vaccine Revenue Market Share Forecast by Application (2027-2032)
